WST - West Pharmaceutical Services
331.40
| Index: | S&P 500 | P/E: | 49.16 | EPS (ttm): | 6.74 | Insider Own: | 0.60% | Shs Outstand: | 72.50M | Perf Week: | 0.41% |
| Market Cap: | 24.32B | Forward P/E: | 44.10 | EPS next Y: | 7.52 | Insider Trans: | -6.99% | Shs Float: | 71.99M | Perf Month: | 6.33% |
| Income(ttm): | 499.60M | PEG: | 19.70 | EPS next Q: | 1.72 | Inst Own: | 96.41% | Short Float: | 1.62% | Perf Quarter: | 8.04% |
| Revenue(ttm): | 2.88B | P/S: | 8.46 | EPS this Y: | -17.63% | Inst Trans: | 0.00% | Short Ratio: | 1.92 | Perf Half Y: | 0.12% |
| Book/sh: | 37.96 | P/B: | 8.73 | EPS next Y: | 12.92% | ROA: | 13.45% | Short Interest: | 1.16M | Perf Year: | -5.18% |
| Cash/sh: | 6.69 | P/C: | 49.55 | EPS next 5Y: | 2.50% | ROE: | 17.78% | 52W Range: | 265.00 - 413.70 | Perf YTD: | -5.88% |
| Dividend Est.: | 0.60 (0.18%) | P/FCF: | 75.63 | EPS past 5Y: | 23.49% | ROI: | 16.44% | 52W High: | -19.89% | Beta: | 1.00 |
| Dividend TTM: | 0.81 (0.24%) | Quick Ratio: | 2.23 | Sales past 5Y: | 11.96% | Gross Margin: | 35.00% | 52W Low: | 25.06% | ATR (14): | 9.22 |
| Dividend Ex-Date: | Nov 13, 2024 | Current Ratio: | 3.00 | EPS Y/Y TTM: | -9.46% | Oper. Margin: | 20.73% | RSI (14): | 57.32 | Volatility: | 2.96% 2.42% |
| Employees: | 10600 | Debt/Eq: | 0.11 | Sales Y/Y TTM: | -1.70% | Profit Margin: | 17.37% | Recom: | 1.92 | Target Price: | 374.50 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.10 | EPS Q/Q: | -13.50% | Payout: | 9.90% | Rel Volume: | 4.02 | Prev Close: | 327.01 |
| Sales Surprise: | 5.25% | EPS Surprise: | 23.28% | Sales Q/Q: | -0.08% | Earnings: | Oct 24 BMO | Avg Volume: | 607.77K | Price: | 331.40 |
| SMA20: | 2.27% | SMA50: | 4.81% | SMA200: | 0.69% | Undervalued: 13.01% | Volume: | 2,444,378 | Change: | 1.34% | |
Graham Classic formula value: 81.71
(P/E=8 * 1g) Min value: 63.55
(current P/E * 2g) Max value: 327.79
Average value: 157.68
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.